Skip to main content

Berta Ferrer Fábrega

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Berta Ferrer Fábrega

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Projects

Tumor dependent immune evasive mechanisms in melanoma

IP: Juan Angel Recio Conde
Collaborators: Paula Granado Martinez, Kimberley Anne McGrail Fernández, Vicente García-Patos Briones, Berta Ferrer Fábrega, Eva Muñoz Couselo, Yuxin Ding , Roberto Orsenigo
Funding agency: Instituto de Salud Carlos III
Funding: 321250
Reference: PI23/00428
Duration: 01/01/2024 - 31/12/2026

Novel therapeutic topical approach for discoid lupus cutaneous (DLE) treatment

IP: Cristina Solé Marce
Collaborators: Berta Ferrer Fábrega, Gloria Aparicio Español
Funding agency: Instituto de Salud Carlos III
Funding: 99099
Reference: PI21/01869
Duration: 01/01/2022 - 31/12/2025

Oncogene-mediated intratumoral immune-cell populations at different organs as biomarkers of immunotherapy response

IP: Juan Angel Recio Conde
Collaborators: Paula Granado Martinez, Kimberley Anne McGrail Fernández, Vicente García-Patos Briones, Berta Ferrer Fábrega, Sara Garcia Ortega, Eva Muñoz Couselo
Funding agency: Instituto de Salud Carlos III
Funding: 341220
Reference: PI20/00384
Duration: 01/01/2021 - 30/04/2024

Modulation of melanoma-stroma interactions using a rationally-designed nanomedicine combining BRAFi-, MEKi- and immunetherapies

IP: Juan Angel Recio Conde
Collaborators: Berta Ferrer Fábrega, Eva Muñoz Couselo
Funding agency: Instituto de Salud Carlos III
Funding: 96072.79
Reference: AC16/00019
Duration: 01/01/2017 - 31/12/2019

Related news

The findings pave the way for the development of new therapeutic strategies combining immunotherapy with p38α protein inhibitors.

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The study reveals that if the exposure of newborns to solar radiation of sufficient intensity to provoke a skin reaction is simultaneous with the activation of the BRAFv600E gene, it can trigger an uncontrolled proliferation of cancer cells.

Related professionals

Sandra Luis Pina

Sandra Luis Pina

Research assistant
Infectious Diseases
Read more
Aleix Cuenca Pellejero

Aleix Cuenca Pellejero

Predoctoral researcher
Systemic Diseases
Read more
Vicente García-Patos Briones

Vicente García-Patos Briones

Head of group
Biomedical Research in Melanoma
Read more
Laura Georgina Teixido Bergada

Laura Georgina Teixido Bergada

Gestió i Administració
Communication Unit
Communication Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.